Agilent Technologies Target of Unusually Large Options Trading (A)

Agilent Technologies (NYSE:A) was the recipient of unusually large options trading on Tuesday. Traders purchased 5,509 call options on the stock. This represents an increase of approximately 1,397% compared to the typical daily volume of 368 call options.

A number of equities analysts have recently weighed in on the company. Morgan Stanley dropped their target price on Agilent Technologies from $95.00 to $91.00 and set an “overweight” rating on the stock in a report on Wednesday, April 11th. Goldman Sachs upgraded Agilent Technologies from a “neutral” rating to a “buy” rating in a report on Monday, April 9th. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $72.00 target price on the stock in a report on Wednesday, April 4th. ValuEngine downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. Finally, JPMorgan Chase increased their price objective on Agilent Technologies from $75.00 to $80.00 and gave the stock an “overweight” rating in a report on Thursday, February 15th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $72.20.

How to Become a New Pot Stock Millionaire

NYSE:A opened at $66.64 on Wednesday. The company has a market capitalization of $21,950.94, a P/E ratio of 28.24, a PEG ratio of 2.34 and a beta of 1.31. The company has a debt-to-equity ratio of 0.40, a quick ratio of 2.78 and a current ratio of 3.23. Agilent Technologies has a 52 week low of $54.51 and a 52 week high of $75.00.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 14th. The medical research company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.58 by $0.08. The firm had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.16 billion. Agilent Technologies had a return on equity of 17.70% and a net margin of 4.25%. During the same quarter in the prior year, the business earned $0.53 earnings per share. sell-side analysts anticipate that Agilent Technologies will post 2.71 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 25th. Shareholders of record on Tuesday, April 3rd will be given a dividend of $0.149 per share. The ex-dividend date is Monday, April 2nd. This represents a $0.60 dividend on an annualized basis and a yield of 0.89%. Agilent Technologies’s payout ratio is currently 25.42%.

In other news, insider Patrick Kaltenbach sold 6,875 shares of the company’s stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $71.38, for a total value of $490,737.50. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Michael R. Mcmullen sold 21,850 shares of the company’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $75.00, for a total value of $1,638,750.00. Following the completion of the transaction, the chief executive officer now owns 324,687 shares in the company, valued at approximately $24,351,525. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 44,550 shares of company stock worth $3,225,202.

Institutional investors have recently made changes to their positions in the business. Front Row Advisors LLC bought a new stake in Agilent Technologies during the fourth quarter worth approximately $106,000. Compagnie Lombard Odier SCmA bought a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $126,000. AMG National Trust Bank bought a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $201,000. Premia Global Advisors LLC bought a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $204,000. Finally, Pinnacle Financial Partners Inc. bought a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $233,000.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Week Herald and is the sole property of of Week Herald. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://weekherald.com/2018/04/25/agilent-technologies-target-of-unusually-large-options-trading-a.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply